Eunsung Global Corp. v. HydraFacial LLC et al.

IPR2025-00453

Eunsung Global Corp. petitions the PTAB to cancel HydraFacial's 11,446,477 skin‑treatment patent, alleging obviousness over several prior‑art references.

Jurisdiction
US PTAB
Case Number
IPR2025-00453
Decision Date
14 January 2025
Filing Date
14 January 2025

Detailed Summary

In Petition IPR2025-00453, Eunsung Global Corp. challenges HydraFacial LLC's U.S. Patent No. 11,446,477, which claims a skin‑treatment system with a manifold, handpiece, vacuum source, and control features. The petitioner asserts that claims 1‑20 are unpatentable under 35 U.S.C. §103, relying on combinations of prior art such as Karasiuk, Palmer, Trueba, Wunsch, and Greenberg. The petition argues the examiner erred by not rejecting the claims based on these references and requests cancellation of all challenged claims.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Eunsung Global Corp. vs HydraFacial LLC et al. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-00990

Mercedes-Benz Group AG et al.vsPhelan Group, LLC

Mercedes‑Benz has filed a petition to institute an IPR against Phelan Group’s U.S. Patent 10,259,470 covering a driver‑authentication and safety system. The petition cites ten grounds of obviousness or anticipation, relying on prior‑art references such as Arshad, Petrik, Siwinski, Wu, Kudo and Murphy. The requester seeks cancellation of all twenty claims.

patentIPR2024-01163

Tommy John, Inc.vsPakage Apparel, Inc.

Tommy John, Inc. successfully petitioned to invalidate key claims of Pakage Apparel's '974 patent based on obviousness over prior art combinations (Kitsch/Brocks). The PTAB declined discretionary denial because the petitioner showed a reasonable likelihood of prevailing and failed to demonstrate material error in prosecution history.

patentIPR2026-00097

Magnolia Medical Technologies, Inc.vsKurin, Inc.

Magnolia Medical Technologies petitions the PTAB to invalidate claims 1‑24 of Kurin’s blood‑sample optimization device, asserting that the Bullington800 publication (alone and combined with Brancazio and Liu) anticipates or makes the claims obvious. The petition seeks institution and cancellation of all challenged claims.

patentIPR2026-00208

Cisco Systems, Inc.vsDamaka, Inc.

Cisco Systems filed an IPR petition seeking to invalidate Damaka's U.S. 9,578,092 patent covering modular video‑conferencing functionality. The petition relies on four prior‑art references to argue obviousness under 35 U.S.C. §103 for claims 1‑30.

patentIPR2026-00098

Google LLCvsSecure Communication Technologies, LLC

Google has filed an IPR petition against Secure Communication Technologies' e‑commerce server patent, challenging 19 claims as obvious over Perttila, Emmons, and Insolia. The petition argues a reasonable likelihood of unpatentability and urges the Board not to deny institution under discretionary standards.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call